Indeed, genetic CXCL12 deletion or pharmacological inhibition of CXCR4 partially prevents BrCa and PrCa metastasis to lungs and bones as well as early steps of intraosseous tumor growth [203,204,219,220,221]. The gene discussed is CXCR4; the disease is neoplasm.